Pershina-Miliutina A P, Eremkina A K, Ozhimalov I D, Khairieva А V, Gorbacheva A M, Ronzhina S V, Mokrysheva N G
I.I. Dedov Endocrinology Research Centre.
Lomonosov Moscow State University.
Probl Endokrinol (Mosk). 2025 Sep 14;71(4):57-70. doi: 10.14341/probl13574.
The main treatment for primary hyperparathyroidism (PHPT) is parathyroidectomy (PTE), conservative therapy, including bisphosphonates, can be used for preoperative correction of hypercalcemia, as well as to improve bone tissue condition among individuals for whom surgery should be postponed or cannot be performed due to high perioperative risks. The question of the effect of bisphosphonates on bone tissue after surgery remains open.
To study the effect of preoperative bisphosphonate therapy on BMD parameters assessed in DXA and 3D-DXA in patients with PHPT one year after radical PTE.
The study was conducted on the basis of the Department of pathology of the parathyroid glands and disorders of mineral metabolism of "Endocrinology Research Center" state-funded research facility of the Ministry of Health of the Russian Federation. The study included 50 patients (2 men, 48 women), divided into two groups depending on the presence or absence of preoperative bisphosphonate (BF) therapy. The methods of DXA and 3D-DXA using 3D-Shaper Medical software were used to evaluate BMD and bone microarchitectonics. The statistical analysis was performed using the R language and the Statistica v.13 package.
At the time of the disease's manifestation, both groups were comparable in terms of the main indicators of calcium phosphorus metabolism, with the exception of the level of beta-crosslapse, which was higher in the group without preoperative BPh therapy (p<0,001). There were also no differences in the parameters of DXA and 3D-DXA. After surgery, both groups showed a comparable increase in BMD based on the results of DXA in the main parts of the skeleton and 3D-DXA in the femur. Changes at the level of the statistical trend were obtained for the 3D-DXA parameters, the final absolute values of which were slightly higher in the second group, including the thickness of the cortical layer in the femur as a whole and in the neck. When comparing the results of DXA before and after PTE in patients receiving BPh, statistically significant differences in absolute BMD values were obtained only in the lumbar spine (p<0,001).According to 3D-DXA data, statistically significant differences were found only in the volume of mineral density of the trabecular bone of the femur as a whole (p=0,001).When analyzing up to - in the second group, statistically significant differences in absolute BMD values were observed in the lumbar region (p<0,001), in the hip as a whole (p<0,001) and in its neck (p=0,001).According to 3D-DXA data, statistically significant differences were found in three of the eight analyzed indicators, the volume of mineral density of the trabecular bone of the femur as a whole and in the neck (p<0,001 for both), as well as the volume of mineral density of the cortical bone in the neck, (p=0,001).
The 3D-DXA method allows us to evaluate not only BMD, but also its microarchitectonics, which is important for predicting the risk of fractures in patients with PHPT. Studies have shown that preoperative BPh therapy can negatively affect the recovery of BMD after PTE, especially in cortical bone tissue. Further studies are needed to confirm these data and clarify the effect of CF on the postoperative course of PHPT.
原发性甲状旁腺功能亢进症(PHPT)的主要治疗方法是甲状旁腺切除术(PTE),保守治疗,包括双膦酸盐类药物,可用于术前纠正高钙血症,以及改善因围手术期风险高而应推迟手术或无法进行手术的患者的骨组织状况。双膦酸盐类药物对术后骨组织的影响问题仍未解决。
研究术前双膦酸盐治疗对根治性PTE术后一年的PHPT患者通过双能X线吸收法(DXA)和三维双能X线吸收法(3D-DXA)评估的骨密度参数的影响。
该研究在俄罗斯联邦卫生部国家资助研究机构“内分泌研究中心”的甲状旁腺病理学和矿物质代谢紊乱科进行。该研究纳入了50例患者(2例男性,48例女性),根据术前是否接受双膦酸盐(BF)治疗分为两组。使用3D-Shaper Medical软件的DXA和3D-DXA方法评估骨密度和骨微结构。使用R语言和Statistica v.13软件包进行统计分析。
在疾病表现时,两组在钙磷代谢的主要指标方面具有可比性,但β-交联羧基末端肽水平除外,未接受术前双膦酸盐治疗的组中该水平较高(p<0.001)。DXA和3D-DXA参数也没有差异。术后,根据DXA结果,两组在主要骨骼部位和股骨的3D-DXA结果显示骨密度有可比的增加。3D-DXA参数在统计趋势水平上有变化,第二组的最终绝对值略高,包括整个股骨和股骨颈的皮质层厚度。在接受双膦酸盐治疗的患者中比较PTE前后的DXA结果时,仅在腰椎获得了骨密度绝对值的统计学显著差异(p<0.001)。根据3D-DXA数据,仅在整个股骨小梁骨矿物质密度体积方面发现统计学显著差异(p = 0.001)。在分析第二组时,在腰椎区域(p<0.001)、整个髋部(p<0.001)及其颈部(p = 0.001)观察到骨密度绝对值的统计学显著差异。根据3D-DXA数据,在八个分析指标中的三个指标上发现统计学显著差异,即整个股骨和股骨颈的小梁骨矿物质密度体积(两者均p<0.001),以及颈部皮质骨矿物质密度体积(p = 0.001)。
3D-DXA方法不仅可以评估骨密度,还可以评估其微结构,这对于预测PHPT患者的骨折风险很重要。研究表明,术前双膦酸盐治疗可能会对PTE术后骨密度的恢复产生负面影响,尤其是在皮质骨组织中。需要进一步研究来证实这些数据并阐明CF对PHPT术后病程的影响。